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ABSTRACT

Background: Aggressive angiomyxomas (AAs) are rare
mesenchymal tumors that are histologically composed of
myxoid stroma and vasculature. AAs are typically located in the
pelvis and perineum and occur more frequently in females of
reproductive age.
Case Presentation: In this report, we outline a patient who had
a paraurethral tumor with histopathology showing a
circumscribed hypocellular lesion with myxoid stroma and
abundant vasculature, consistent with the diagnosis of
aggressive angiomyxoma. The mass was excised with
resolution of symptoms and the patient was advised to continue
close follow-up with her gynecologist and endocrinologist to
monitor for recurrence.
Conclusion: Due to its rarity, aggressive angiomyxomas are
often misdiagnosed as cysts, hernias, lipomas, or cancerous
lesions. Although benign, close follow-ups are crucial to monitor
for recurrences.

Subjective: 31-year-old G1P1 premenopausal female with a past medical history
significant for fibroids, presented to the office for evaluation of a possible pelvic
mass. She complained of vaginal itching, pelvic pressure with discomfort, and
noted copious brown and purulent discharge with no foul odor.
Objective:
Physical examination: swollen and tender spherical lesion adhered to the left
anterior vaginal wall
Procedure: Pt was taken to OR under general anesthesia for excision of the
mass which measured 3.55 cm x 2.0 cm x 1.5 cm [Figure 1].
Histopathology: A circumscribed hypocellular lesion with myxoid stroma and
abundant vasculature, with focally infiltrating fibroadipose tissue consistent with
the diagnosis of aggressive angiomyxoma [Figure 2].
Assessment & Plan:
The patient was then discharged with a Foley catheter in place, appropriate
antibiotics, and pain medications. She reported improvement in her symptoms at
her follow-up appointment 4 days later, and the Foley catheter was removed at
this time. She was advised to continue close follow-up with her gynecologist and
an endocrinologist was incorporated for her care.

INTRODUCTION

AAs tend to be misdiagnosed as cysts, hernias, lipomas, or
cancerous lesions due to their rarity and cystic mass-like
appearance. Surgery is the first-line treatment for AAs with the
goal of complete resection [10]. When characterized as
aggressive, angiomyxomas have a high recurrence rate of 30%
due to their infiltrating qualities and absence of capsule, making it
difficult for a complete resection with clear margins. 71% of
recurrences happen within three years of the primary resection of
AA. Most AAs are either hormone-dependent or hormonesensitive, leading to a higher likelihood of presentation in
premenopausal women [4]. Hormonal therapies with continuous
GnRH agonist or ER or PR antagonist can be beneficial to
prevent reoccurrence. In primary tumors that are too large to
resect, hormonal therapies have been shown to shrink the AAs to
a manageable size where they can be resected with clear
margins. Since the nature and the timing of the hormonal
therapies remain unestablished, the treatment plan is best
managed with a multidisciplinary team of OB/GYNs and
endocrinologists to minimize the likelihood of recurrence [11].
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